Key Highlights
•
Researchers have identified a new RNA-modifying enzyme, Mettl8, that helps maintain the stem-like state of exhausted T cells, which are crucial for fighting cancer. Inhibiting Mettl8 pushes these cells to become more effective cancer fighters and works even better when combined with existing immunotherapy drugs.
Source →
•
A new study shows that targeting two antioxidant proteins, PRDX6 and GSTP1, together can force aggressive neuroblastoma cancer cells to mature into less dangerous, non-dividing cells. This “differentiation therapy” approach offers a promising new strategy to treat this childhood cancer by changing the cancer’s behavior instead of just trying to kill it.
Source →
•
Scientists are rethinking how contractility, the force that makes cells move and change shape, works in the complex, active meshwork inside cells called the cytoskeleton. This new perspective is crucial for understanding fundamental processes like cell division, wound healing, and how cancer cells spread.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
